Ho Chao-Hung
Division of Hematology, Taipei Veterans General Hospital, Taiwan, ROC.
Zhonghua Yi Xue Za Zhi (Taipei). 2002 Feb;65(2):55-60.
Serum ferritin is known as a good tool to diagnose iron status. Recently the soluble serum transferrin receptor (sTfR) has been introduced as a promising new tool for diagnosing iron depletion. The present study was to compare the differential diagnostic values of sTfR and other related parameters in different causes of anemia.
Two hundred and nine subjects enrolled into this study were divided into 7 groups. Group A included 50 healthy controls; Group B included 54 patients with iron deficiency anemia (IDA); Group C included 34 patients with anemia of chronic disorders (ACD); Group D included 9 patients with thalassemia; Group E included 34 patients with anemia of other causes; Group F included 8 patients with thalassemia associated with IDA and Group G included 17 patients with IDA associated with ACD. Serum transferrin receptor (sTfR), ferritin, total iron-binding capacity (TIBC), unbound iron-binding capacity (UIBC) and complete blood count were measured in these subjects. In 17 patients with IDA, serum ferritin, sTfR, hemoglobin were rechecked after iron therapy for at least eight weeks and their data were compared.
sTfR could differentiate IDA from the healthy and ACD, but was unable to differentiate ACD from ACD associated with IDA, nor IDA from IDA associated with ACD. Transferrin saturation, sTfR/Ferritin and sTfR/log Ferritin were the best to differentiate ACD from ACD associated with IDA. In comparison with sTfR or serum ferritin alone, sTfR/Ferritin and sTfR/log Ferritin were better to distinguish ACD from ACD associated with IDA and IDA associated with thalassemia. Serum ferritin was better to distinguish IDA from IDA associated with thalassemia, or uncomplicated IDA from other causes of anemia, but was not so good to distinguish complicated IDA from others. It was also more sensitive than sTfR to indicate the iron repletion in the patient with IDA after iron therapy.
sTfR is a new diagnostic tool to distinguish patients with anemia. Its diagnostic ability can further improve in combination with serum ferritin, transferrin saturation and other related parameters.
血清铁蛋白是诊断铁状态的良好工具。最近,可溶性血清转铁蛋白受体(sTfR)作为一种有前景的诊断铁缺乏的新工具被引入。本研究旨在比较sTfR和其他相关参数在不同贫血病因中的鉴别诊断价值。
纳入本研究的209名受试者分为7组。A组包括50名健康对照者;B组包括54名缺铁性贫血(IDA)患者;C组包括34名慢性病贫血(ACD)患者;D组包括9名地中海贫血患者;E组包括34名其他病因的贫血患者;F组包括8名合并IDA的地中海贫血患者;G组包括17名合并ACD的IDA患者。检测这些受试者的血清转铁蛋白受体(sTfR)、铁蛋白、总铁结合力(TIBC)、未结合铁结合力(UIBC)及全血细胞计数。对17名IDA患者进行至少8周的铁剂治疗后复查血清铁蛋白、sTfR、血红蛋白,并比较其数据。
sTfR能区分IDA与健康对照者及ACD,但无法区分ACD与合并IDA的ACD,也不能区分IDA与合并ACD的IDA。转铁蛋白饱和度、sTfR/铁蛋白及sTfR/log铁蛋白在区分ACD与合并IDA的ACD方面表现最佳。与单独的sTfR或血清铁蛋白相比,sTfR/铁蛋白及sTfR/log铁蛋白在区分ACD与合并IDA的ACD以及合并地中海贫血的IDA方面表现更好。血清铁蛋白在区分IDA与合并地中海贫血的IDA,或单纯IDA与其他病因的贫血方面表现较好,但在区分复杂IDA与其他情况方面效果不佳。在指示IDA患者铁剂治疗后的铁补充情况方面,血清铁蛋白也比sTfR更敏感。
sTfR是区分贫血患者的一种新诊断工具。其诊断能力与血清铁蛋白、转铁蛋白饱和度及其他相关参数联合使用时可进一步提高。